Home - Products - Angiogenesis - EGFR - WHI-P258

WHI-P258

CAS No. 21561-09-1

WHI-P258( WHI-P258 | WHI-P 258 | WHI-P-258 | WHIP 258 )

Catalog No. M13440 CAS No. 21561-09-1

WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	32	In Stock
5MG	28	In Stock
10MG	46	In Stock
25MG	88	In Stock
50MG	137	In Stock
100MG	233	In Stock
200MG	341	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

WHI-P258
Note

Research use only, not for human use.
Brief Description

WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
Description

WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK binding negative control in the development of new therapeutics.
In Vitro

——
In Vivo

——
Synonyms

WHI-P258 | WHI-P 258 | WHI-P-258 | WHIP 258
Pathway

Angiogenesis
Target

EGFR
Recptor

EGFR| JAK3
Research Area

——
Indication

——

Chemical Information

CAS Number

21561-09-1
Formula Weight

281.31
Molecular Formula

C16H15N3O2
Purity

>98% (HPLC)
Solubility

DMSO: <1.2mg/mL
SMILES

COC1=CC2=NC=NC(NC3=CC=CC=C3)=C2C=C1OC
Chemical Name

6,7-Dimethoxy-N-phenylquinazolin-4-amine

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Mobocertinib

Mobocertinib is a potent ?inhibitor of epidermal growth factor receptor (EGFR) and an antineoplastic agent.
Olmutinib

Olmutinib is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase InhibitorOlmutinib at 3 μM significantly reversed drug resistance mediated by ABCG2, but not by ABCB1 and ABCC1, by antagonizing the drug efflux function in ABCG2-overexpressing cells.?
Avitinib maleate

Avitinib maleate (AC-0010MA, AC0010 maleate) is an?orally available, irreversible, and mutant-selective EGFR inhibitor with IC50 of 0.18 nM against EGFR L858R/T790M.

Sign In Join Free